These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
601 related articles for article (PubMed ID: 32244228)
1. Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosis. Huang Q; Chen Y; Shen S; Wang Y; Liu L; Wu S; Xu W; Zhao W; Lin M; Wu J Aging (Albany NY); 2020 Apr; 12(7):5812-5831. PubMed ID: 32244228 [TBL] [Abstract][Full Text] [Related]
2. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis. Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083 [TBL] [Abstract][Full Text] [Related]
3. Hsp90 regulation of fibroblast activation in pulmonary fibrosis. Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659 [TBL] [Abstract][Full Text] [Related]
4. SEMA3B inhibits TGFβ-induced extracellular matrix protein production and its reduced levels are associated with a decline in lung function in IPF. Yombo DJK; Ghandikota S; Vemulapalli CP; Singh P; Jegga AG; Hardie WD; Madala SK Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1659-C1668. PubMed ID: 38646784 [TBL] [Abstract][Full Text] [Related]
5. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis. Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491 [No Abstract] [Full Text] [Related]
7. SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis. Tu M; Lu C; Jia H; Chen S; Wang Y; Li J; Cheng J; Yang M; Zhang G J Transl Med; 2024 Oct; 22(1):885. PubMed ID: 39354547 [TBL] [Abstract][Full Text] [Related]
8. Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis. Herrera J; Beisang DJ; Peterson M; Forster C; Gilbertsen A; Benyumov A; Smith K; Korenczuk CE; Barocas VH; Guenther K; Hite R; Zhang L; Henke CA; Bitterman PB Am J Respir Crit Care Med; 2018 Aug; 198(4):486-496. PubMed ID: 29579397 [TBL] [Abstract][Full Text] [Related]
9. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production. Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709 [TBL] [Abstract][Full Text] [Related]
10. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways. Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003 [TBL] [Abstract][Full Text] [Related]
11. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis. Zhang L; Li Y; Liang C; Yang W Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150 [TBL] [Abstract][Full Text] [Related]
12. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling. Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047 [TBL] [Abstract][Full Text] [Related]
13. YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF. Chen Y; Zhao X; Sun J; Su W; Zhang L; Li Y; Liu Y; Zhang L; Lu Y; Shan H; Liang H Cell Death Differ; 2019 Sep; 26(9):1832-1844. PubMed ID: 30644438 [TBL] [Abstract][Full Text] [Related]
14. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation. Aravamudhan A; Haak AJ; Choi KM; Meridew JA; Caporarello N; Jones DL; Tan Q; Ligresti G; Tschumperlin DJ Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L852-L863. PubMed ID: 32159970 [TBL] [Abstract][Full Text] [Related]
15. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis. Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381 [TBL] [Abstract][Full Text] [Related]
16. Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis. Mümmler C; Burgy O; Hermann S; Mutze K; Günther A; Königshoff M FASEB J; 2018 Feb; 32(2):703-716. PubMed ID: 28986417 [TBL] [Abstract][Full Text] [Related]
17. LncRNA PFAR contributes to fibrogenesis in lung fibroblasts through competitively binding to miR-15a. Sun J; Su W; Zhao X; Shan T; Jin T; Guo Y; Li C; Li R; Zhou Y; Shan H; Sun X; Liang H Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31273058 [TBL] [Abstract][Full Text] [Related]
18. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis. Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339 [TBL] [Abstract][Full Text] [Related]
19. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state. Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654 [TBL] [Abstract][Full Text] [Related]
20. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs. Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]